RxDoctor Payments Data

Ahmer Ghori, MD

Orthopaedic Surgery of the Spine · Fort Wayne, INNPI 1881914356

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (50.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Spineart SA at 35.3% of the total.

$219,731in general payments, 2019–2025

Across 213 payments — averaging $1031.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Spineart SA$77K
  • Spineart USA Inc$40K
  • The Institute Of Musculoskeletal Science And Education$37K
  • Zimmer Biomet$27K
  • Wenzel Spine, Inc.$15K
  • Orthofix Medical, Inc.$13K
  • plus $11K from 13 others

What the payments were for

  • Royalty or licence$110,48050%
  • Consulting fees$53,22524%
  • Speaking & faculty fees$17,6758%
  • Travel & lodging$30,11614%
  • Food & beverage$8,2354%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$219,731 in reported general payments places this provider in the 70th percentile of 48 orthopaedic surgery of the spine providers in Indiana.

See all orthopaedic surgery of the spine providers in Indiana

Medicare billing

Part B allowed, 2024
$161,032
Medicare patients
280
Services billed
803

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin96$681
Prednisone82$281
Gabapentin14$150
Methylprednisolone20$128
Tizanidine Hcl14$103

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Fort Wayne

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →